A surprise amount of Brits say they would take anti-obesity drugs if they were given to them for free on the NHS.
Glucagon-like peptide-1 (GLP-1) agonist are a family of medications that help manage blood sugar in patients with type 2 diabetes, but have also been found to help obese people lose weight.
The drugs include Mounjaro, also known as tirzepatide, and semaglutide, which is sold under the brand names Wegovy, Ozempic and Rybelsus.
The survey of 1,078 adults, carried out by Ipsos, found 24% of people would use weight-loss jabs if they were provided for free by the health service.
When asked about their own body image, four in 10 told the survey they think they are overweight or obese.
Not for free, but paid by people’s taxes and insurance contributions.
Drugs have a cost, and there’s always someone paying. With national health insurance, the people getting drugs are the ones paying it. It’s just spread over a large group, and a function of individuals income.